Literature DB >> 6341145

Glycaemic control in pancreatectomized dogs with a wearable artificial endocrine pancreas.

M Shichiri, R Kawamori, Y Goriya, Y Yamasaki, M Nomura, N Hakui, H Abe.   

Abstract

A needle-type glucose sensor has been developed using a platinum electrode covered with immobilized glucose oxidase. Experiments with albumin-saline solution in vitro showed that at 5.5 mmol/l glucose concentration the output current generated was 1.2 +/- 0.4 nA (mean +/- SD). The current increased as a linear function of glucose concentration over the range (0-27.7 mmol/l). The response time to reach 90% of the final plateau value was 16.2 +/- 6.2s. The signal-to-noise ratio of the sensor was 15.8 +/- 2.6 decibels. The temperature coefficient in output was 2.3 +/- 1.0%/degrees C. The current output was not affected significantly by changes in oxygen tension of the solution in the range 25-150 mmHg. In vivo, the output current of sensors inserted into the subcutaneous tissues of dogs was directly related to blood glucose concentrations after oral glucose or meals. Daily checking of the sensors maintained in subcutaneous tissues in five dogs showed that the sensitivity decreased gradually to 87.2 +/- 7.6% at 72 h, and dropped significantly to 57.4 +/- 7.0% of the initial output by 96 h. A wearable artificial endocrine pancreas (18.0 x 17.7 x 7.9 cm, 700 g) was developed, consisting of a needle-type glucose sensor, a microcomputer system and a pump driving mechanism. Three pancreatectomized dogs were fitted with the system by inserting the sensor into subcutaneous tissue. By renewing the sensor every fourth day, the device could maintain the daily glucose variations in diabetic dogs within the range 5-9.5 mmol/l for 7 days.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6341145     DOI: 10.1007/bf00250158

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  13 in total

1.  THE M-VALVE, AN INDEX OF BLOOD-SUGAR CONTROL IN DIABETICS.

Authors:  J SCHLICHTKRULL; O MUNCK; M JERSILD
Journal:  Acta Med Scand       Date:  1965-01

2.  Continuous percutaneous monitoring of muscle pH and oxygen pressure. A new technique for in vivo use.

Authors:  A Wakabayashi; Y Nakamura; T Woollley; P J Mullin; H Watanabe; T Ino; J E Connolly
Journal:  Arch Surg       Date:  1975-07

3.  Importance of insulin secretion based on the rate of change in blood glucose concentration in glucose tolerance, assessed by the artificial beta cell.

Authors:  R Kawamori; M Shichiri; Y Goriya; Y Yamasaki; Y Shigeta; H Abe
Journal:  Acta Endocrinol (Copenh)       Date:  1978-02

4.  A simple method for the determination of serum free insulin levels in insulin-treated patients.

Authors:  S Nakagawa; H Nakayama; T Sasaki; K Yoshino; Y Y Yu
Journal:  Diabetes       Date:  1973-08       Impact factor: 9.461

5.  The metabolic response to glycemic control by the artificial pancreas in diabetic man.

Authors:  B Zinman; E F Stokes; A M Albisser; A K Hanna; H L Minuk; A N Stein; B S Leibel; E B Marliss
Journal:  Metabolism       Date:  1979-05       Impact factor: 8.694

6.  Oxygen and carbon dioxide tensions in tissue and blood of normal and acidotic rats.

Authors:  H D Van Liew
Journal:  J Appl Physiol       Date:  1968-11       Impact factor: 3.531

7.  Mean amplitude of glycemic excursions, a measure of diabetic instability.

Authors:  F J Service; G D Molnar; J W Rosevear; E Ackerman; L C Gatewood; W F Taylor
Journal:  Diabetes       Date:  1970-09       Impact factor: 9.461

8.  Continuous extracorporeal monitoring of animal blood using the glucose electrode.

Authors:  E C Layne; R D Schultz; L J Thomas; G Slama; D F Sayler; S P Bessman
Journal:  Diabetes       Date:  1976-02       Impact factor: 9.461

9.  Sustained insulin-induced remissions of juvenile diabetes by means of an external artificial pancreas.

Authors:  J Mirouze; J L Selam; T C Pham; E Mendoza; A Orsetti
Journal:  Diabetologia       Date:  1978-04       Impact factor: 10.122

10.  Perfect normalization of excessive glucagon responses to intravenous arginine in human diabetes mellitus with the artificial beta-cell.

Authors:  R Kawamori; M Shichiri; M Kikuchi; Y Yamasaki; H Abe
Journal:  Diabetes       Date:  1980-09       Impact factor: 9.461

View more
  11 in total

1.  Drug delivery by program or sensor controlled infusion devices.

Authors:  M Franetzki
Journal:  Pharm Res       Date:  1984-11       Impact factor: 4.200

2.  Mathematical simulation of an amperometric enzyme-substrate electrode with a pO2 basic sensor. Part 2. Mathematical simulation of the glucose oxidase glucose electrode.

Authors:  K Lemke
Journal:  Med Biol Eng Comput       Date:  1988-09       Impact factor: 2.602

Review 3.  Synthetic hydrogels as drug delivery systems.

Authors:  W E Roorda; H E Boddé; A G De Boer; J A Bouwstra; H E Junginer
Journal:  Pharm Weekbl Sci       Date:  1986-06-20

4.  Subcutaneous implantation of a ferrocene-mediated glucose sensor in pigs.

Authors:  D J Claremont; I E Sambrook; C Penton; J C Pickup
Journal:  Diabetologia       Date:  1986-11       Impact factor: 10.122

5.  Assessment and optimisation of dip-coating procedure for the preparation of electroenzymic glucose transducers.

Authors:  P A Rea; P Rolfe; P J Goddard
Journal:  Med Biol Eng Comput       Date:  1985-03       Impact factor: 2.602

Review 6.  Technology and the diabetic patient.

Authors:  J C Pickup; D Rothwell
Journal:  Med Biol Eng Comput       Date:  1984-09       Impact factor: 2.602

7.  Automated feedback control of subcutaneous glucose concentration in diabetic dogs.

Authors:  K Rebrin; U Fischer; T von Woedtke; P Abel; E Brunstein
Journal:  Diabetologia       Date:  1989-08       Impact factor: 10.122

8.  Towards continuous glucose monitoring: in vivo evaluation of a miniaturized glucose sensor implanted for several days in rat subcutaneous tissue.

Authors:  D Moatti-Sirat; F Capron; V Poitout; G Reach; D S Bindra; Y Zhang; G S Wilson; D R Thévenot
Journal:  Diabetologia       Date:  1992-03       Impact factor: 10.122

9.  Glucagon in the metabolic and nutritional management after total pancreatectomy--a case report.

Authors:  M Hirota; S Ikei; M Mishima; K Mori; K Sakamoto; T Yamane; K Idegami; S Katafuchi; H Kiyohara; Y Nakashima
Journal:  Jpn J Surg       Date:  1989-09

Review 10.  What is artificial endocrine pancreas? Mechanism and history.

Authors:  Kenro Nishida; Seiya Shimoda; Kenshi Ichinose; Eiichi Araki; Motoaki Shichiri
Journal:  World J Gastroenterol       Date:  2009-09-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.